A Public Company Cannot Run on Sage 50 and a Workaround
This case study shows how Hepion Pharmaceuticals, a NASDAQ-listed biopharma company, outgrew Sage 50 and Bill.com, leading to recurring audit issues and manual financial processes. It highlights how NetSuite, implemented by Archer Insights, replaced both systems with a single, audit-ready platform—automating controls, consolidations, and payments while improving accuracy and compliance.